Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | HTR6 | P50406 | 1/20 | 0.57 |
| ▸ | ESRRG | P62508 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8644765 | 0.91 | SMN1; SMN2 (0.44) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL9188866 | 0.88 | ESR1 (0.52) | ESR1ESR2CYP3A4ARHPGD | |
| Methacrylic Acid SCHEMBL1123736 | 0.87 | ESR1 (0.43) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL1123616 | 0.86 | ESR1 (0.53) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL12050061 | 0.81 | LTA4H (0.66) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL5531121 | 0.80 | ESR1 (0.50) | ESR1ESR2CYP3A4ARHPGD | |
| Bisphenol A SCHEMBL9764202 | 0.79 | ESR1 (0.70) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL30547354 | 0.79 | MAPT (0.45) | HPGDTSHRHSD17B10ALDH1A1LMNA | |
| SCHEMBL11142902 | 0.78 | ESR1 (0.52) | ESR1ESR2CYP3A4ARHPGD | |
| SCHEMBL23007619 | 0.77 | ESR1 (0.55) | ESR1ESR2CYP3A4ARHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117326588-A | Preparation method of nano zirconia powder and dispersion liquid and brightness enhancement film | 东莞市光志光电有限公司 | 2024-01-02 | — | — | CN | disclosed |
| US-9684233-B2 | Curable composition for imprints, patterning method and pattern | FUJIFILM CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| EP-2284205-B1 | METHOD FOR PRODUCING AN OPTICAL COMPONENT | SOKEN KAGAKU KK (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-20140159261-A1 | METHOD OF PRODUCING OPTICAL COMPONENT | SOKEN CHEMICAL & ENGINEERING CO., LTD. (JP) | 2014-06-12 | — | — | US | disclosed |
| EP-2499659-A1 | CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN | FUJIFILM Corporation (JP) | 2012-09-19 | — | — | EP | disclosed |
| US-20120225263-A1 | CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN | FUJIFILM CORPORATION (JP) | 2012-09-06 | — | — | US | disclosed |
| WO-2011059104-A1 | CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN | FUJIFILM CORPORATION (JP) | 2011-05-19 | — | — | WO | disclosed |
| US-20110077318-A1 | RESIN COMPOSITION FOR PRODUCING OPTICAL COMPONENT AND USE THEREOF | OMRON CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-2284205-A1 | RESIN COMPOSITION FOR MANUFACTURING OPTICAL COMPONENT AND APPLICATION THEREOF | Omron Corporation (JP) | 2011-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110077318-A1 | RESIN COMPOSITION FOR PRODUCING OPTICAL COMPONENT AND USE THEREOF | CAD, RER1, ALG3 | ESR1 2655/4885ESR2 3567/4885CYP3A4 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.